News Quantified

AVDL – avadel pharmaceuticals plc - american depositary shares each representing one ordinary share (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Assessing Avadel Pharmaceuticals (AVDL) Valuation After Strong 1-Year Share Price Performance [Yahoo! Finance]

Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 REVITALYZ™ Trial in Idiopathic Hypersomnia

Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plc - AVDL

Form 8.3 [Yahoo! Finance]

Form 8.3 [Yahoo! Finance]

14.8%

BEAT

5.7%

BEAT

-13.5%

IN-LINE

-13.5%

IN-LINE

Form DEFA14A AVADEL PHARMACEUTICALS

Form 8-K AVADEL PHARMACEUTICALS For: Dec 18

Form DEFA14A AVADEL PHARMACEUTICALS

Form 8-K AVADEL PHARMACEUTICALS For: Dec 08

Form DEFM14A AVADEL PHARMACEUTICALS

Top News Gainers

2/21 Avadel Pharmaceuticals Announces $65 Million Private Placement with Leading Biotech Investment Funds 32.0%

6/13 Form 8-K AVADEL PHARMACEUTICALS For: Jun 13 20.4%

6/5 Form 8-K AVADEL PHARMACEUTICALS For: May 30 20.0%

3/24 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $7.75 price target on the stock. 18.2%

9/23 Avadel Pharmaceuticals Announces FDA Agreement to Reduce the Sample Size for the Ongoing Pivotal Phase 3 Study for Once-Nightly FT218; Full Enrollment Now Expected by End of 2019 17.6%

6/10 Form 8-K AVADEL PHARMACEUTICALS For: Jun 04 17.0%

5/24 Form 4 AVADEL PHARMACEUTICALS For: May 22 Filed by: Ende Eric J 15.5%

9/17 Avadel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference on September 24th 15.4%

11/19 Form 4 AVADEL PHARMACEUTICALS For: Nov 15 Filed by: Ende Eric J 14.3%

4/27 Form DEF 14A AVADEL PHARMACEUTICALS For: Aug 05 13.4%

Top News Decliners

3/12 Q4/2019 12/31/2019 EPS -0.070 ZacksConsensus -0.250 ActVsEst 0.180 - Beat -20.7%

4/27 Form 8-K AVADEL PHARMACEUTICALS For: Apr 27 -14.9%

4/28 Avadel Pharmaceuticals Announces Pricing of Public Offering -12.1%

8/8 Avadel Pharmaceuticals Receives New PDUFA Date for AV001 of December 15, 2019 -11.4%

7/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -9.8%

6/3 Avadel Pharmaceuticals Appoints Gregory J. Divis Chief Executive Officer -8.8%

9/25 Form 8-K AVADEL PHARMACEUTICALS For: Sep 25 -8.7%

11/12 Form 8-K AVADEL PHARMACEUTICALS For: Nov 12 -8.3%

10/2 Avadel Pharmaceuticals PLC (NASDAQ: AVDL) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -8.0%

8/30 Fresenius Kabi Introduces Phenylephrine Hydrochloride Injection, USP -7.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day